The 7th International Symposium on Focused Ultrasound will address a wide range of topics as the field of focused ultrasound continues to grow.
The program will explore the latest in using focused ultrasound to treat a range of conditions across oncology, neurology, women's health, cardiovascular disease, pediatrics, and more. We will also address challenges to widespread adoption – such as technology gaps and commercialization efforts.
The following is a detailed list of topics that will be covered at the symposium.
Brain
- Movement disorders
- Neurodegenerative disorders
- Psychiatric disorders
- Epilepsy
- Neuromodulation
- Pain
- Brain tumors
- Blood-brain barrier opening
Cancer & Benign Tumors
- Immunotherapy
- Liquid biopsy
- Prostate
- Pancreatic
- Liver & biliary tract
- Colorectal
- Esophageal
- Lung
- Kidney
- Bladder
- Head and neck
- Bone
- Melanoma
- Thyroid
- Ovarian
- Breast
- Uterine fibroids and adenomyosis
- Soft tissue tumors: desmoid, sarcoma, neurofibromatosis
Musculoskeletal
- Arthritis: hand, hip, knee, ankle
- Back pain: facetogenic, sacroiliac
- Rotator cuff
Cardiovascular
- Valve calcifications
- Atrial fibrillation
- Cardiac hypertrophy
- Congestive heart failure
- Congenital heart anomalies
- Peripherial arterial disease
- Varicose veins
- Deep vein thrombosis
Veterinary
- Arthritis
- Soft tissue tumors
- Bone tumors
- Liver tumors
- Bladder tumors
- Brain tumors
- Spay/neuter
- Oral melanoma
- Chronic wound healing
Education
- Educational opportunities
- Training, credentialing, certification
Commercialization
- Regulatory
- Reimbursement: coding and billing
- Site success
- Advocacy
- Financing
- Employment opportunities
- Investment opportunities
Research
- Funding opportunities
- Data sharing and open science
- Clinical trials
- Registries
- Employment opportunities
History & Future of Focused Ultrasound
- State of the field
- Globalization
Technology
- Commercial offerings
- Breakthroughs
- Gaps
- Standards and quality assurance
- Simulation and patient selection
- Treatment planning, monitoring, and evaluation
Mechanisms of Action
- Tissue destruction
- Therapeutic delivery
- Radiation sensitization
- Clot lysis
- Stem cell homing
If you wish to receive email communications about the meeting, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..